Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
17.10
-0.58 (-3.28%)
At close: Sep 11, 2026, 4:00 PM EDT
17.34
+0.24 (1.40%)
After-hours: Sep 11, 2026, 7:45 PM EDT
Janux Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
| 10.27 | 3.73 | - | 10 | - | - | - | 0.44 | 8.9 | 1.25 | 2.46 | 2.52 | 1.06 | 2.05 | 2.85 | 1.81 | 2.37 | 1.59 | 1.62 | 1.16 | |
Revenue Growth (YoY) | - | - | - | 2177.90% | - | - | - | -82.56% | 741.72% | -38.87% | -13.50% | 38.83% | -55.31% | 28.89% | 76.05% | 56.43% | 390.66% | 318.16% | - | - |
Cost of Revenue | 30.99 | 26.81 | 31.55 | 34.63 | 34.66 | 25.06 | 20.81 | 18.61 | 14.9 | 14.07 | 12.24 | 11.89 | 14.92 | 15.87 | 15.43 | 13.74 | 14.09 | 10.18 | 11.17 | 8.41 |
Gross Profit | -20.73 | -23.08 | -31.55 | -24.63 | -34.66 | -25.06 | -20.81 | -18.18 | -6 | -12.82 | -9.78 | -9.38 | -13.87 | -13.82 | -12.59 | -11.92 | -11.72 | -8.6 | -9.55 | -7.25 |
Selling, General & Admin | 10.96 | 11.13 | 10.85 | 10.62 | 10.45 | 9.84 | 8.22 | 17.67 | 7.82 | 7.34 | 6.36 | 6.44 | 6.88 | 6.46 | 5.68 | 6.1 | 5.54 | 4.95 | 3.94 | 3.66 |
Operating Expenses | 10.96 | 11.13 | 10.85 | 10.62 | 10.45 | 9.84 | 8.22 | 17.67 | 7.82 | 7.34 | 6.36 | 6.44 | 6.88 | 6.46 | 5.68 | 6.1 | 5.54 | 4.95 | 3.94 | 3.66 |
Operating Income | -31.69 | -34.21 | -42.4 | -35.25 | -45.12 | -34.9 | -29.02 | -35.84 | -13.82 | -20.16 | -16.14 | -15.81 | -20.75 | -20.28 | -18.27 | -18.02 | -17.26 | -13.54 | -13.49 | -10.9 |
Interest & Investment Income | 9.72 | 9.85 | 10.46 | 10.94 | 11.26 | 11.39 | 8.81 | 7.78 | 7.86 | 5.4 | 4.38 | 4.25 | 3.24 | 2.82 | 2.2 | 1.33 | 0.37 | 0.13 | 0.07 | 0.14 |
Pretax Income | -21.97 | -24.36 | -31.95 | -24.31 | -33.86 | -23.51 | -20.22 | -28.06 | -5.96 | -14.76 | -11.76 | -11.57 | -17.51 | -17.46 | -16.07 | -16.7 | -16.89 | -13.41 | -13.42 | -10.77 |
Net Income | -21.97 | -24.36 | -31.95 | -24.31 | -33.86 | -23.51 | -20.22 | -28.06 | -5.96 | -14.76 | -11.76 | -11.57 | -17.51 | -17.46 | -16.07 | -16.7 | -16.89 | -13.41 | -13.42 | -10.77 |
Net Income to Common | -21.97 | -24.36 | -31.95 | -24.31 | -33.86 | -23.51 | -20.22 | -28.06 | -5.96 | -14.76 | -11.76 | -11.57 | -17.51 | -17.46 | -16.07 | -16.7 | -16.89 | -13.41 | -13.42 | -10.77 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 63 | 63 | 62 | 62 | 62 | 62 | 57 | 55 | 54 | 49 | 47 | 46 | 42 | 42 | 42 | 42 | 41 | 41 | 41 | 41 |
Shares Outstanding (Diluted) | 63 | 63 | 62 | 62 | 62 | 62 | 57 | 55 | 54 | 49 | 47 | 46 | 42 | 42 | 42 | 42 | 41 | 41 | 41 | 41 |
Shares Change (YoY) | 1.67% | 1.41% | 9.35% | 13.54% | 13.68% | 25.98% | 21.74% | 19.52% | 30.15% | 17.45% | 12.26% | 10.07% | 0.94% | 1.09% | 0.91% | 0.95% | 313.11% | 3618.17% | 4003.90% | 4259.12% |
EPS (Basic) | -0.35 | -0.39 | -0.51 | -0.39 | -0.55 | -0.38 | -0.36 | -0.51 | -0.11 | -0.30 | -0.25 | -0.25 | -0.42 | -0.42 | -0.39 | -0.40 | -0.41 | -0.32 | -0.33 | -0.26 |
EPS (Diluted) | -0.35 | -0.39 | -0.51 | -0.39 | -0.55 | -0.38 | -0.36 | -0.51 | -0.11 | -0.30 | -0.25 | -0.25 | -0.42 | -0.42 | -0.39 | -0.40 | -0.41 | -0.32 | -0.33 | -0.26 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Free Cash Flow | 12.28 | -12.61 | -28.65 | -12.95 | -24.29 | -17.4 | -16.77 | -2.26 | -10.12 | -15.03 | -10.42 | -12.18 | -15.63 | -14.2 | -13.97 | -15.93 | -6.97 | -12.49 | -11.65 | -5.93 |
Free Cash Flow Per Share | 0.20 | -0.20 | -0.46 | -0.21 | -0.39 | -0.28 | -0.29 | -0.04 | -0.19 | -0.31 | -0.22 | -0.27 | -0.37 | -0.34 | -0.34 | -0.38 | -0.17 | -0.30 | -0.28 | -0.14 |
Gross Margin | -201.88% | - | - | -246.29% | - | - | - | - | -67.45% | - | - | - | - | - | - | - | - | - | - | - |
Operating Margin | -308.66% | -916.50% | - | -352.51% | - | - | - | -8164.47% | -155.36% | -1610.30% | -655.71% | -628.25% | -1962.91% | -990.28% | -642.04% | -994.04% | -729.85% | -852.23% | -834.78% | -940.72% |
Profit Margin | -214.01% | -652.59% | - | -243.13% | - | - | - | -6391.57% | -66.98% | -1178.91% | -477.77% | -459.60% | -1656.39% | -852.49% | -564.67% | -920.90% | -714.08% | -843.93% | -830.20% | -928.90% |
Free Cash Flow Margin | 119.63% | -337.80% | - | -129.49% | - | - | - | -513.89% | -113.70% | -1200.80% | -423.24% | -483.87% | -1479.09% | -693.16% | -491.00% | -878.88% | -294.76% | -786.22% | -721.16% | -511.73% |
EBITDA | -31.23 | -33.74 | -41.93 | -34.75 | -44.58 | -34.38 | -28.51 | -35.33 | -13.32 | -19.63 | -15.61 | -15.31 | -20.28 | -19.83 | -17.86 | -17.77 | -17.15 | -13.46 | -13.43 | -10.88 |
EBITDA Margin | - | - | - | - | - | - | - | - | -149.67% | - | - | - | - | - | - | - | - | - | - | - |
D&A For EBITDA | 0.46 | 0.47 | 0.47 | 0.5 | 0.54 | 0.52 | 0.51 | 0.51 | 0.51 | 0.53 | 0.53 | 0.5 | 0.47 | 0.45 | 0.4 | 0.25 | 0.11 | 0.08 | 0.06 | 0.03 |
EBIT | -31.69 | -34.21 | -42.4 | -35.25 | -45.12 | -34.9 | -29.02 | -35.84 | -13.82 | -20.16 | -16.14 | -15.81 | -20.75 | -20.28 | -18.27 | -18.02 | -17.26 | -13.54 | -13.49 | -10.9 |
EBIT Margin | - | - | - | - | - | - | - | - | -155.36% | - | - | - | - | - | - | - | - | - | - | - |